Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6050778B2 - tannin - Google Patents
[go: Go Back, main page]

JPS6050778B2 - tannin - Google Patents

tannin

Info

Publication number
JPS6050778B2
JPS6050778B2 JP16180784A JP16180784A JPS6050778B2 JP S6050778 B2 JPS6050778 B2 JP S6050778B2 JP 16180784 A JP16180784 A JP 16180784A JP 16180784 A JP16180784 A JP 16180784A JP S6050778 B2 JPS6050778 B2 JP S6050778B2
Authority
JP
Japan
Prior art keywords
gal
acetone
ppm
cooh
vii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP16180784A
Other languages
Japanese (ja)
Other versions
JPS6064947A (en
Inventor
五夫 西岡
源一郎 野中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to JP16180784A priority Critical patent/JPS6050778B2/en
Publication of JPS6064947A publication Critical patent/JPS6064947A/en
Publication of JPS6050778B2 publication Critical patent/JPS6050778B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 本発明は医薬品として有用なタンニン及びその製造法に
関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to tannins useful as pharmaceuticals and methods for producing the same.

タンニンは広く植物界に分布し、収れん作用のあるとこ
ろから収れん薬として、また皮を革に変化させるなめし
剤として多く用いられてきた。
Tannins are widely distributed in the plant kingdom, and have been widely used as an astringent due to their astringent properties, and as a tanning agent to transform hides into leather.

タンニンは分子量600〜2000ほどで複雑な構造を
有しており、単離精製の困難さとあいまつて研究が遅れ
ていた。一方、従来よりうらじろがし等の酵素阻害作用
等に基づく有用な医薬的効果が知られており、本発明者
らは、多くの植物より新規のタンニンを単離取得して薬
理効果を検べ、酵素阻害作用を見出た七た。
Tannins have a molecular weight of about 600 to 2,000 and a complex structure, which, combined with the difficulty of isolation and purification, has delayed research. On the other hand, useful medicinal effects have been known based on enzyme inhibitory effects such as tannins, and the present inventors have isolated and obtained novel tannins from many plants to demonstrate their pharmacological effects. I tested it and found that it had an enzyme inhibitory effect.

本発明に係る化合物は、体中酵素蛋白と結合することに
よつてその活性を低下させることが判つている。本発明
に係る化合物は、代謝調節剤として有用である。
It has been found that the compounds according to the present invention reduce the activity of enzyme proteins in the body by binding to them. Compounds according to the invention are useful as metabolic regulators.

本発明に係る化合物はすへて文献未載の新規化合物であ
る。本発明に係る化合物は、楊梅皮、桂皮、机椰子、地
検、菱実、ウラジロガシ皮、コケモモ葉等の植物から、
アセトンによる抽出、酢酸エチル:”水の分配、カラム
クロマト等公知の方法により容易に得ることができる。
The compound according to the present invention is a novel compound that has not yet been described in any literature. The compounds according to the present invention can be obtained from plants such as Yang Mei Peel, cinnamon bark, desk palm, district copse, lozenge, Japanese oak bark, lingonberry leaf, etc.
It can be easily obtained by known methods such as extraction with acetone, ethyl acetate: water partitioning, column chromatography, etc.

本発明による抽出方法を総括して示せば例えば次のよう
である。以下実施例を掲げて詳細に説明する。
The extraction method according to the present invention can be summarized as follows, for example. Examples will be described in detail below.

実施例1 ウラジロガシ皮6.3k9を80%の水性アセトン5′
て抽出し、アセトンを留去後、水溶性を酢酸エチル1e
で約10回分液、酢酸エチル可溶部をあつめ、Seph
aadexl.H−20で溶媒エタノール、80%水性
メタノールを使い、カラムクロマト分離精製したところ
、以下の物質45mgを得た。
Example 1 80% aqueous acetone 5'
After distilling off the acetone, remove the water solubility with ethyl acetate.
Separate the solution about 10 times, collect the ethyl acetate soluble part, and add Seph
aadexl. When column chromatographic separation and purification was performed using H-20 as a solvent and 80% aqueous methanol, 45 mg of the following substance was obtained.

無色無定形粉末。Colorless amorphous powder.

〔α〕。−102.8。(c=0.32,acet0n
e)PMR(AcetOne−Cl6)Ppm:2.1
0−2.50(4H,m,C2,6−H),4.50(
1H,d−11ke,J=4Hz,C5−H),5.2
5(1H,dd,J=7,4Hz,C,−H),5.6
0−5.93(1H,m,C3−H),7.05,7.
11(Each2H,s,gal,H)。
[α]. -102.8. (c=0.32, acet0n
e) PMR (AcetOne-Cl6) Ppm: 2.1
0-2.50 (4H, m, C2, 6-H), 4.50 (
1H, d-11ke, J=4Hz, C5-H), 5.2
5 (1H, dd, J=7,4Hz, C, -H), 5.6
0-5.93 (1H, m, C3-H), 7.05, 7.
11 (Each2H, s, gal, H).

CMR(AcetOne−DG)Ppm:38.0(C
2),39.0(C6),68.5(C5),68.7
(C3),75.2(C1),75.5(C4),10
9.7,109.8(?11.C2,6),120.6
(Gal.Cl×2),138.7(Gal.C4x2
),145.5(Gal.C3,5×2),166.3
,166.6(−COO−),177.5(COOH)
。3.4−Di−0−GallOylqujnicac
id.同様にして3,5−Dj−0−GallOylq
uinicAcjd無色無定形 粉末(収率0.006
%)を得た。
CMR (AcetOne-DG) Ppm: 38.0 (C
2), 39.0 (C6), 68.5 (C5), 68.7
(C3), 75.2 (C1), 75.5 (C4), 10
9.7,109.8(?11.C2,6),120.6
(Gal.Cl×2), 138.7(Gal.C4x2
), 145.5 (Gal.C3, 5×2), 166.3
, 166.6 (-COO-), 177.5 (COOH)
. 3.4-Di-0-GallOylqujnicac
id. Similarly, 3,5-Dj-0-GallOylq
uinicAcjd Colorless amorphous powder (yield 0.006
%) was obtained.

〔α〕o−63.00(c=0.20,acet0ne
)PMR(AcetOne−(16)Ppm:2.33
(4H,d一11ke,j=7Hz,C2,6−H),
4.14(1H,dd,j=7.4Hz,C4−H),
5.40−5.68(2H,m,C3,5−H),7.
13,7.19(Each2H,s,gal.H)。C
MR(AcetOne−D6)Ppm:35.7(C6
),37.5(C2),70.1(C4),72.0(
C3),72.1(C,),74.2(C1),109
.8(Gal.C2,6×2),121.4,121.
9(Gal.Cl),138.3,138.6(Gal
.C4),145.5(Gal.C3,5×2),16
6.1(−COO−×2),175.8(−COOH)
。同様にして4,5−Di−0−GallOylqui
nicaCld黄かつ色無定形粉末(収率0.005%
)を得た。
[α]o-63.00 (c=0.20, acet0ne
)PMR(AcetOne-(16)Ppm: 2.33
(4H, d-11ke, j=7Hz, C2,6-H),
4.14 (1H, dd, j=7.4Hz, C4-H),
5.40-5.68 (2H, m, C3,5-H), 7.
13, 7.19 (Each2H, s, gal.H). C
MR (AcetOne-D6) Ppm: 35.7 (C6
), 37.5 (C2), 70.1 (C4), 72.0 (
C3), 72.1 (C,), 74.2 (C1), 109
.. 8 (Gal.C2, 6×2), 121.4, 121.
9 (Gal.Cl), 138.3, 138.6 (Gal.
.. C4), 145.5 (Gal.C3, 5×2), 16
6.1 (-COO- x 2), 175.8 (-COOH)
. Similarly, 4,5-Di-0-GallOylqui
nicaCld yellow and colored amorphous powder (yield 0.005%
) was obtained.

〔α〕o−116.5形(AcetOne,c=0.3
6),MSm/s:788(M+)PMR(AcetO
ne−D6)Ppm:2.25〜2.76(4H9m9
c296−H),5.52(1H,dd,j=8.3H
z,C4−H)″,5.72〜5.96(2FI,m,
C3,5一H),7.05,7.09,7.16(Ea
ch?,S,gal.H)。
[α] o-116.5 type (AcetOne, c=0.3
6), MSm/s: 788 (M+) PMR (AcetO
ne-D6) Ppm: 2.25-2.76 (4H9m9
c296-H), 5.52 (1H, dd, j=8.3H
z, C4-H)'', 5.72-5.96 (2FI, m,
C3,5-H), 7.05, 7.09, 7.16 (Ea
Ch? , S, gal. H).

CMR(AcetOne−D6)Ppm:36.2(T
,C6),38.1(T,C2),68.8(D,C3
),69.7(D,C5),72.1(D,C4),7
4.1(S,Cl),109.8(D,gall.C2
,C6×3),120.4,121.1(S,gall
.Cl×3),138.7,139.8(S,gaI.
C4×3),145.5(S,gal.C3,5×3)
,166.2(S,−COO−×3),176.2(−
COOH)。同様にして3,4,5−Tri−0−Ga
llOylquinicacid無色無定形粉末(収率
0.005%)を得た。〔α〕o−35.5d(Ace
tOne,c=0.19),PMR(AcetOne−
D6)Ppm:2.10−.2.50(4H,m,C2
,6−H),4.53(1H,sex,j=8.6Hz
,C3−H),5.17(1H,dd,J=9Hz,3
Hz,C5−H),7.08,7.13(Each2H
,s,gal.H)。
CMR (AcetOne-D6) Ppm: 36.2 (T
, C6), 38.1 (T, C2), 68.8 (D, C3
), 69.7 (D, C5), 72.1 (D, C4), 7
4.1(S,Cl), 109.8(D,gall.C2
,C6×3),120.4,121.1(S,gall
.. Cl×3), 138.7, 139.8 (S, gaI.
C4 x 3), 145.5 (S, gal. C3, 5 x 3)
,166.2(S,-COO-×3),176.2(-
COOH). Similarly, 3,4,5-Tri-0-Ga
llOylquinicacid colorless amorphous powder (yield 0.005%) was obtained. [α]o-35.5d(Ace
tOne, c=0.19), PMR(AcetOne-
D6) Ppm: 2.10-. 2.50 (4H, m, C2
, 6-H), 4.53 (1H, sex, j=8.6Hz
, C3-H), 5.17 (1H, dd, J=9Hz, 3
Hz, C5-H), 7.08, 7.13 (Each2H
,s,gal. H).

CMR(AcetOne−D6)Ppm:36・7(C
6)941・6(C2),65.5(C3),69.7
(C5),74.6(C1),75.9(C4),10
9.9(Gall.C2,C6×2),121.3,1
21.7(?11.C1),138.3,138.5(
?1.C4),145.5(?1.C3,5×2),1
65.8,166.1(−COO−),176.5(−
COOH)。実施例2 ウラジロガシ皮6.3kgを水性アセトン5′で抽出し
、酢酸エチル1′で分液、酢酸エチル可溶部をあつめ、
SephadexLH−20でカラムクロマト分離をく
り返し、精製したところ、以下のGaIlOylque
ritOl類を得た。
CMR (AcetOne-D6) Ppm: 36.7 (C
6) 941.6 (C2), 65.5 (C3), 69.7
(C5), 74.6 (C1), 75.9 (C4), 10
9.9 (Gall. C2, C6 x 2), 121.3, 1
21.7 (?11.C1), 138.3, 138.5 (
? 1. C4), 145.5 (?1.C3,5×2), 1
65.8, 166.1 (-COO-), 176.5 (-
COOH). Example 2 Extract 6.3 kg of the skin of Japanese oak with 5' aqueous acetone, separate the liquid with 1' ethyl acetate, collect the ethyl acetate soluble part,
After repeated column chromatography separation using Sephadex LH-20 and purification, the following GaIlOylque was obtained.
ritOls were obtained.

1無色無定形粉末(収率0.7%) 〔α〕D−107.7(c=0.67,Me0H)PM
R(AcetOne−D6+CD3OD)Ppm:2.
04−2.20(211,m,C6−H),3.29−
4.16(3H,m,C1,2,3−H),5.38(
1H,dd,J=10,6Hz,C5−H),5.60
(1H,t,J=10Hz,C4−H),6.98,7
.04(Each2l(,S,gal.H)CMR(A
cetOne−D6+CD3OD)Ppm:32.7(
T,C6),69.4(D,Cl),70.7(D,C
6),71.4(D,C3),73.9(D,C2),
75.6(D,C4),109.7,109.8(D,
gal.C2,6),121.1,121.3(S,g
al.Cl),138.6(S,gaI.C4×2),
145.8(S,gal.C3,5×2),166.6
,167.4(S,−COO−)4,5−Di−0−G
aIlOylqurecitOl2無色針状晶(収率0
.006%)Mp255−2580C 〔α〕o−10.50(c=0.68,acet0ne
)PMR(AcetOne−D6)Ppm:2.10−
2.30(2H,m,C6−H),4.18,4.29
(EachlH,s−11ke,C192−H)95.
40−5●76(?9n9c395−H),5.90(
1H,t,J=10Hz,C4−H),7.00,7.
05,7.08(Each2H,s,gal,H)。
1 Colorless amorphous powder (yield 0.7%) [α]D-107.7 (c=0.67, Me0H) PM
R(AcetOne-D6+CD3OD)Ppm:2.
04-2.20 (211, m, C6-H), 3.29-
4.16 (3H, m, C1,2,3-H), 5.38 (
1H, dd, J=10,6Hz, C5-H), 5.60
(1H, t, J=10Hz, C4-H), 6.98, 7
.. 04(Each2l(,S,gal.H)CMR(A
cetOne-D6+CD3OD)Ppm:32.7(
T, C6), 69.4 (D, Cl), 70.7 (D, C
6), 71.4 (D, C3), 73.9 (D, C2),
75.6 (D, C4), 109.7, 109.8 (D,
gal. C2, 6), 121.1, 121.3 (S, g
al. Cl), 138.6 (S, gaI.C4×2),
145.8 (S, gal. C3, 5×2), 166.6
,167.4(S,-COO-)4,5-Di-0-G
aIlOylqurecitOl2 colorless needle crystals (yield 0
.. 006%) Mp255-2580C [α]o-10.50 (c=0.68, acet0ne
) PMR (AcetOne-D6) Ppm: 2.10-
2.30 (2H, m, C6-H), 4.18, 4.29
(EachlH, s-11ke, C192-H)95.
40-5●76(?9n9c395-H), 5.90(
1H, t, J=10Hz, C4-H), 7.00, 7.
05, 7.08 (Each2H, s, gal, H).

Claims (1)

【特許請求の範囲】 1 次の一般式〔VII〕 ▲数式、化学式、表等があります▼〔VII〕(R^1^
5は水素又は−COOHを表わし、R^1^6は水素又
は水酸基を表わし、R^1^7、R^1^8、R^1^
9は同一又は異なつて水素又はガロイル基▲数式、化学
式、表等があります▼以下「G」と略す。 )を表わす。ただし、R^1^7、R^1^8、R^1
^9のうちいずれか2つ以上がガロイル基である場合に
限る。)で表わされる新規タンニン。
[Claims] 1 The following general formula [VII] ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [VII] (R^1^
5 represents hydrogen or -COOH, R^1^6 represents hydrogen or a hydroxyl group, R^1^7, R^1^8, R^1^
9 is the same or different hydrogen or galloyl group ▲ Numerical formula, chemical formula, table, etc. ▼ Hereinafter abbreviated as "G". ). However, R^1^7, R^1^8, R^1
Only when any two or more of ^9 are galloyl groups. ) is a new tannin.
JP16180784A 1984-07-31 1984-07-31 tannin Expired JPS6050778B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16180784A JPS6050778B2 (en) 1984-07-31 1984-07-31 tannin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16180784A JPS6050778B2 (en) 1984-07-31 1984-07-31 tannin

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP56120372A Division JPS6011912B2 (en) 1981-07-30 1981-07-30 tannin

Publications (2)

Publication Number Publication Date
JPS6064947A JPS6064947A (en) 1985-04-13
JPS6050778B2 true JPS6050778B2 (en) 1985-11-11

Family

ID=15742285

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16180784A Expired JPS6050778B2 (en) 1984-07-31 1984-07-31 tannin

Country Status (1)

Country Link
JP (1) JPS6050778B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980034292A (en) * 1996-11-06 1998-08-05 성재갑 Skin whitening composition containing galloylquinic acid

Also Published As

Publication number Publication date
JPS6064947A (en) 1985-04-13

Similar Documents

Publication Publication Date Title
EP0264173B1 (en) Bryostatins
US4210581A (en) Organic compounds
Fried et al. The hypotensive principles of Veratrum viride
US5441932A (en) Sugar compounds for inhibition of the biosynthesis of sugar chains containing sialic acid
JPS62142181A (en) Novel tannin
JPS6248677A (en) Novel tannin
JPH0229078B2 (en)
JPS6050778B2 (en) tannin
JPS6011912B2 (en) tannin
US4895852A (en) Antitumor alkaloids
JPS6157594A (en) Galactosphingolipid and its production
JPH0246598B2 (en) SHINKINARUTANNIN
JPWO1995004041A1 (en) Carbazole compounds
JPS6353993B2 (en)
US4092412A (en) Treatment of herpes simplex infections
DE69323998T2 (en) PHARMACEUTICAL ACTIVE FLAVILIUM COMPOUNDS
JPH01500516A (en) Guaiazulene derivatives and their usage
DK160828B (en) METHOD FOR PREPARING A REACTION PRODUCT OF 2-METHYL-2,5-DIMETHOXY-2,5-DIHYDRO-FURAN AND L-ASCORBIC ACID
JPS61112090A (en) Novel tannin
JPS6249277B2 (en)
JPH07285877A (en) Reverse transcriptase inhibitor of hiv-1
JPS6348213A (en) Antitumor agent
Gramshaw et al. 571. Gallotannins. Part V. The structure of penta-and tetra-O-galloylglucoses, and some observations on the molecular weights of the gallotannins
JPS6249278B2 (en)
JPS59184158A (en) Clavulone derivative